News

Tonix Pharmaceuticals has no tonic for cocaine intoxication, with the biopharma terminating a midstage trial for the ...
Recent research indicates that the use of psychedelics has the potential to significantly reduce the experience of chronic ...
A Sarasota biopharmaceutical company is applying for a patent for an Alzheimer’s drug. Silo Pharma, based on North Washington ...
Silo Pharma (NASDAQ: SILO) announced the filing of a patent application with the U.S. Patent and Trademark Office for SPC-14, a novel intranasal comp ...
Research suggests that better understanding the psychological and neurological components of chronic pain may lead to better ...
A routine becomes easier to maintain when you have the right tools to support it. Get ready for bed like a sleep editor with ...
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel ...
The global chronic pain market is set to experience robust growth, with projections estimating it will reach an impressive USD 78,186.20 million in 2024. Driven by a confluence of factors including ...